ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 105 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $65,000 | -58.6% | 11,431 | -48.2% | 0.00% | -60.0% |
| Q2 2022 | $157,000 | -30.5% | 22,053 | -29.4% | 0.01% | -28.6% |
| Q1 2022 | $226,000 | -13.4% | 31,254 | +7.1% | 0.01% | -12.5% |
| Q4 2021 | $261,000 | -83.1% | 29,184 | -33.8% | 0.01% | -87.3% |
| Q3 2021 | $1,546,000 | +222.1% | 44,095 | +97.2% | 0.06% | +215.0% |
| Q2 2021 | $480,000 | – | 22,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |